[The possibility of participation of the Sanarelli-Shwartzman phenomenon in the pathogenesis of the hemorrhagic syndrome in radiation sickness].
D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D001772:Blood Cell Count; D001780:Blood Coagulation Tests; D001799:Blood Sedimentation; D003036:Cobalt Isotopes; D005260:Female; D005340:Fibrinogen / Q000097:blood; D006474:Hemorrhagic Disorders / Q000209:etiology*; D007275:Injections, Intravenous; D007668:Kidney / Q000473:pathology; D008297:Male; D008551:Melena / Q000175:diagnosis; D011817:Rabbits; D011833:Radiation Injuries, Experimental / Q000097:blood / Q000150:complications* / Q000473:pathology; D012790:Shwartzman Phenomenon / Q000150:complications*; D014655:Vascular Resistance
D000614:Aminocaproates; D000925:Anticoagulants; D003036:Cobalt Isotopes; D005340:Fibrinogen
Uber die Möglichkeit der Beteiligung des Sanarelli-Shwartzman-Phänomens an der Pathogenese des hämorrhagischen Syndroms bei der Strahlenkrankheit.